|
Sign In to gain access to subscriptions and/or personal tools.
|
Modern Management of the Migrane Headache
Kimberly A. Pesaturo, PharmD*
and
Fae G. Wooding, PharmD
* To whom correspondence should be addressed. E-mail: kimberly.pesaturo{at}mcphs.edu.
 |
Abstract |
|---|
Migraine headache is a debilitating disorder that affects millions of people in the United States and worldwide. The diagnosis of migraine can significantly affect quality of life, health care costs, and daily productivity. Hundreds of trials and many guidelines have documented various approaches to migraine management, whether via acute treatment or chronic migraine prophylaxis. Acute or abortive migraine management encompasses specific and nonspecific migraine therapeutics, including nonopioid and opioid analgesics, triptans, and ergotamines. Prophylactic migraine management data span the pharmacological spectrum from antiepileptic and antihypertensive agents to botulinum toxin type A. Special considerations for migraine management also must be applied in various populations, including children, pregnant women, and the elderly. The following review serves as an introduction to current therapeutic approaches for acute migraine treatment and provides an overview of available literature for pharmacological prophylaxis.
First published on December 19, 2008, doi:10.1177/1559827608327916
American Journal of Lifestyle Medicine 2009;3:147.
A more recent version of this article appeared on March 1, 2009
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
